ECS
ECSBOTANIC FPO [ECS]
Healthcare · ASX Small Cap
$0.0060 +0.0%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when ECS triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Watch out — volume is flowing out even as price holds up. Distribution pattern
- Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
- Trading above the 200-day average — the long-term trend is on your side
- Strong cash runway (21 quarters)
- Very high P/S ratio (2653.7x)
- Micro-cap ($5-20M) - high risk
- CANSLIM A: Turned profitable
- Sentiment is mixed — no strong consensus either way
- The bigger volume days are the up days — volume-weighted momentum is positive (5.04%/day)
- Altman Z-Score distress zone (0.65 < 1.81, low-confidence approx)
- Penny stock risk ($0.006)
- RBA hiking (-3pts)
Risk Signals
- Piotroski F-Score weak (2/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 21% over the past year
Expected next for ECS
Window: 5 Oct to 23 Oct
The last 9 moved ECS -4.1% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE ECS FY26 Results
NONE Appendix 4G & Corporate Governance Statement
NONE Change of Share Registry
LOW Appendix 4E & Annual Report
LOW ECS Investor Presentation
Recent ASX Announcements
| 2026-08-27 | ECS FY26 Results PRICE SENSITIVE |
| 2026-08-27 | Appendix 4E & Annual Report PRICE SENSITIVE |
| 2026-08-27 | Appendix 4G & Corporate Governance Statement |
| 2026-07-30 | Change of Share Registry |
| 2026-07-28 | ECS Investor Presentation |
Key Metrics
$9.6M
Market Cap
719K
Avg Volume
1.5x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
N/A
Cash Runway
N/A
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | improving | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | insufficient_data | Float: 0% |
| L | Leader vs Laggard | pass | RS: 20 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track ECS and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required